Replies to post #377366 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

If he doesn’t present at CTAD it’s a big missed opportunity

No biotech CEO would miss that kind of once-in-a-lifetime opportunity; that is, showcasing internationally a successful advanced AD trial. And there is no way CTAD would give up releasing such news at its conference and any and all rules would be adjusted to accommodate a late-breaking situation. Finally, there is no way for me to believe that top line data plus more would not be available five months following that successful trial's conclusion. That's where we are.

[Gernee20]

If he wanted to present at ctad something deeper then TLD, the cutoff was September 30th. But, If data was locked last week, there is no way they would have submitted a late breaking abstract. Based on this timeline, I don’t believe they will be at ctad. Obviously this can all change if, for example, they locked the data beginning of September.